دورية أكاديمية
Corneal perforation secondary to gonococcal keratoconjunctivitis.
| العنوان: | Corneal perforation secondary to gonococcal keratoconjunctivitis. |
|---|---|
| المؤلفون: | Kiritoshi S; Department of Ophthalmology, Osaka University Graduate School of Medicine, Osaka, Japan., Soma T; Department of Ophthalmology, Osaka University Graduate School of Medicine, Osaka, Japan soma@ophthal.med.osaka-u.ac.jp. |
| المصدر: | CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne [CMAJ] 2020 Nov 02; Vol. 192 (44), pp. E1361. |
| نوع المنشور: | Case Reports; Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Canadian Medical Association Country of Publication: Canada NLM ID: 9711805 Publication Model: Print Cited Medium: Internet ISSN: 1488-2329 (Electronic) Linking ISSN: 08203946 NLM ISO Abbreviation: CMAJ Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: Ottawa : Canadian Medical Association Original Publication: [Ottawa] : The Association = L'Association, [1985]- |
| مواضيع طبية MeSH: | Corneal Perforation/*microbiology , Gonorrhea/*complications , Keratoconjunctivitis/*microbiology, Anti-Bacterial Agents/therapeutic use ; Cefmenoxime/therapeutic use ; Ceftriaxone/therapeutic use ; Corneal Perforation/therapy ; Corneal Transplantation ; Drug Therapy, Combination ; Erythromycin/therapeutic use ; Gonorrhea/drug therapy ; Humans ; Keratoconjunctivitis/therapy ; Male ; Young Adult |
| مستخلص: | Competing Interests: Competing interests: Takeshi Soma reports receiving a grantin-aid for scientific research from the Japan Society for the Promotion of Science (KAKENHI; grant no. JP18K09407) and personal fees from Hoya Vision, Santen Pharmaceutical, Otsuka Pharmaceutical, Nitto Medic, Pfizer, Senju Pharmaceutical and Alcon. No other competing interests were declared. |
| References: | Eye (Lond). 2009 Feb;23(2):339-44. (PMID: 18064057) Int Ophthalmol. 2015 Feb;35(1):135-40. (PMID: 25544662) Eye (Lond). 2015 Jul;29(7):875-80. (PMID: 25907207) MMWR Recomm Rep. 2015 Jun 5;64(RR-03):1-137. (PMID: 26042815) |
| المشرفين على المادة: | 0 (Anti-Bacterial Agents) 63937KV33D (Erythromycin) 75J73V1629 (Ceftriaxone) KBZ4844CXN (Cefmenoxime) |
| تواريخ الأحداث: | Date Created: 20201103 Date Completed: 20210524 Latest Revision: 20210524 |
| رمز التحديث: | 20231215 |
| مُعرف محوري في PubMed: | PMC7647476 |
| DOI: | 10.1503/cmaj.200506 |
| PMID: | 33139425 |
| قاعدة البيانات: | MEDLINE |
Full Text via ClinicalKey 
Full Text Finder | تدمد: | 1488-2329 |
|---|---|
| DOI: | 10.1503/cmaj.200506 |